Research progress on dosage and segmentation of thoracic radiotherapy for limited-stage small cell lung cancer
10.3760/cma.j.issn.1004-4221.2019.06.015
- VernacularTitle:局限期小细胞肺癌胸部放疗剂量和分割方式研究进展
- Author:
Jinbiao XU
1
;
Feng QIU
Author Information
1. 赣州市肿瘤医院肿瘤科 341000
- Keywords:
Lung neoplasms/radiotherapy;
Dosage and segmentation;
Research progress
- From:
Chinese Journal of Radiation Oncology
2019;28(6):463-466
- CountryChina
- Language:Chinese
-
Abstract:
At present,surgery,systemic chemotherapy,thoracic radiotherapy and prophylactic cranial irradiation have been widely recognized to treat the limited-stage small cell lung cancer.In recent decades,no significant breakthrough has been reached in drug therapy.In the field of radiotherapy,the timing,target volume,mode of dose fractionation and prophylactic cranial irradiation are the hot issues.In this article,the research progress on the dose and the mode of dose fractionation for limited-stage small cell lung cancer was briefly analyzed.
